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Abstract: The purpose of this study was to compare the fertile phase of the menstrual cycle as
determined by the Clearplan Easy Fertility Monitor (CPEFM) with self-monitoring of cervical
mucus. One-hundred women (mean age = 29.4 years) observed their cervical mucus and
monitored their urine for estrogen and luteinizing hormone metabolites with the CPEFM on a daily
basis for 2–6 cycles and generated 378 cycles of data; of these, 347 (92%) had a CPEFM peak.
The beginning of the fertile window was, on average, day 11.8 (SD = 3.4) by the monitor and day
9.9 (SD = 3.0) by cervical mucus (r = 0.43, p < 0.001). The average first day of peak fertility by the
monitor was 16.5 (SD = 3.6) and by cervical mucus 16.3 (SD = 3.7) (r = 0.85, p < 0.001). The
mean length of the fertile phase by the monitor was 7.7 days (SD = 3.1) and by cervical mucus
10.9 days (SD = 3.7) (t = 12.7, p < 0.001). The peak in fertility as determined by the monitor and by
self-assessment of cervical mucus is similar but the monitor tends to underestimate and
self-assessment of cervical mucus tends to overestimate the actual fertile phase.

1. Introduction
Researchers have demonstrated that there is a potential 6-day window of fertility in a
woman’s menstrual cycle and that peak fertility occurs on the 2 days preceding ovulation [1, 2].
The fertile window includes the 5 days before ovulation and the day of ovulation. The accurate
determination of those 6 days of fertility (i.e., the fertile phase) and the peak of fertility is critical for
women and couples who wish to use natural biological markers to achieve or avoid pregnancy.
Self-monitoring of cervical-vaginal mucus is one of the most common biological markers
used in the self-assessment of the fertile window. The estrogen rise from a ripening follicle in each
menstrual cycle stimulates cervical mucus production and indicates the beginning of fertility. The
cervical mucus progresses from a tacky cloudy appearance to a clear, slippery, watery
consistency at the peak of fertility. The peak in cervical mucus correlates closely with the day of
ovulation and indicates the beginning of the end of the fertile window [3, 4]. However, cervical
mucus can at times be a confusing and subjective biological marker [4–7].
The Clearplan Easy Fertility Monitor (CPEFM; Unipath Diagnostics Company, Princeton,
NJ, USA) is a new electronic device that has been developed to help women to determine their
fertile window [8]. The CPEFM measures urinary metabolites of estrogen and luteinizing hormone
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(LH) and provides the user with a daily indication of “low,” “high” and “peak” fertility. The monitor is
currently sold and marketed in the United States only as a device to aid in achieving pregnancy.
Evidence from the manufacturer shows that, on average, the monitor will provide the user with
3–5 days of high to peak fertility [8]. Research also shows a strong correlation of the CPEFM
“peak” with the actual day of ovulation as determined by serial transvaginal ultrasound and serum
measures of LH [9]. Used alone, the CP monitor does not always provide a long enough warning
before fertility to be used as a device to prevent pregnancy. A pregnancy could occur because
sperm can live from 3–5 days in cervical mucus before the actual day of ovulation. If the CPEFM
is used in conjunction with the information provided by other natural markers of fertility (i.e.,
cervical mucus), the information and feedback provided by each marker might facilitate a more
accurate determination of the fertile window. The specific objective of this study was to compare
the beginning, peak, and length of fertility in a woman’s menstrual cycle as determined by the
CPEFM with the beginning, peak and length of the fertile period as determined by self-monitoring
of cervical mucus. The comparison was made with a 6-day fertile phase as the standard for
comparison (i.e., the day of ovulation and the 5 days preceding ovulation). The estimated day of
ovulation was defined as the day after the LH surge or, i.e., the second “peak” day on the CPEFM.

2. Materials and methods
Potential women participants were recruited from a university clinic and a private medical
practice. The first 100 healthy women who were seeking to learn how to monitor their fertility for
the purpose of avoiding pregnancy were taught how to observe their cervical mucus and were
invited to monitor their urine for estrogen and LH metabolites with the CPEFM on a daily basis for
two to six cycles. Criteria for participation were that the participant be between the ages of 18 and
42 years; have a menstrual cycle range of 21–42 days; had not used depot medroxyprogesterone
acetate over the past 12 months; had no history of oral or subdermal contraceptives for the past 3
months; if post-breastfeeding, to have experienced at least three cycles past weaning and have
no known fertility problems. All 100 participants signed a research consent form approved by a
university office of research compliance before beginning the study. The same office approved
the research protocol as meeting Federal regulations for human subject protection.
2.1. Measurement of fertility by the CPEFM
The CPEFM is a handheld electronic device that provides the users with a daily reading of
“low,”“high” or “peak” fertility. The high reading of the monitor indicates the rising level of urinary
estrone-3-gluconuride (E3G) and the peak reading indicates the surge in urinary LH. The monitor
will automatically provide 2 days of “peak” readings followed by 1 day of “high.” For this study, the
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fertile period for the CPEFM was defined from the first day of a “high” reading until 1 full day past
the last “peak” day, i.e., all “high” and “peak” readings on the monitor.
The CPEFM is based on urinary hormonal immunoassay techniques. Product testing has
shown the CPEFM to be 98.8% accurate in detecting the LH surge [8]. The CPEFM detected the
LH surge in 169 of 171 cycles from 88 women, in agreement with a quantitative
radioimmunoassay for LH. Detection of urinary metabolites of urinary estradiol (E3G) has been
recognized by the World Health Organization (WHO) as a reliable marker for the beginning of the
fertile phase of the menstrual cycle [10]. In a study with 90 women who used the CPEFM for 1–4
cycles, in 352 cycles with an LH surge, the first day of high fertility (i.e., the day of the threshold
rise in E3G) was 3.01 ± 2.33 days before the LH surge [8].
The CPEFM is initiated when the user pushes a button on the monitor labeled “M” on the
first day of her menses. The monitor then indicates which day of the cycle the user is on. The
monitor requests either 10 or 20 daily urine tests per cycle. When the monitor requests a test, the
user places the test strip under her urine stream for 3 s only. The test strip is then placed in the
monitor and read. The participants in this study recorded on a specially designed fertility chart
their fertility status (low, high or peak) and any intercourse that occurred on a daily basis.
2.2. Measurement of the fertile period by monitoring cervical mucus
The beginning of the fertile period was defined as the first day that cervical mucus is
observed or felt. The peak day of cervical mucus is the last day of clear, stretchy and/or slippery
mucus. The end of the fertile period is the third day past the peak day. These are standard criteria
for the fertile period as defined by the ovulation method (OM) and are the criteria that were used in
the WHO (1983) multicountry study of the OM [11]. The women participants were asked to
observe their cervical mucus on a daily basis (i.e., at each void) and to make mental notes of the
sensations and observed characteristics. The mucus was rated on a 1–8 scale (with 1 = “dry
sensation, no mucus” to 7 = “stretchy, slippery and clear” or 8 = “slippery sensation, variable
amount”). The “peak” day of cervical mucus observations was defined as the last day of the 7 or 8
rating—which in effect was the last day of “clear, stretchy, or slippery mucus.” The mucus ratings
were modified from a scale used by Flynn and Lynch in a study that correlated self-assessed
mucus with plasma levels of LH [12]. The cervical mucus observations and ratings were recorded
daily on a fertility chart. Two certified professional nurse natural family planning (NFP) teachers
verified the beginning and peak of the fertile period on each NFP chart. A 100% inter-rater
agreement was obtained on a random selection of 30 charts for the (CPEFM and cervical mucus)
beginning and peak day.
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2.3. Data analysis
Information from the fertility charts were entered into a computer data set and analyzed
with the 10.1 version of the Statistical Package for the Social Sciences (SPSS). To compare the
fertile phase of the CPEFM with the fertile phase of cervical mucus monitoring, a mean, range,
and standard deviation of the day of the beginning, peak, and length of each fertile period were
determined. A Pearson’s correlation was calculated between each of the variables of the CPEFM
fertile phase with the cervical mucus fertile phase. A paired t test was calculated to determine if
there were any significant differences between the mean day of the beginning, peak and length of
the fertile phase between the two methods of fertility monitoring.

3. Results
3.1. Demographics
The 100 women participants had a mean age of 29.5 years (SD = 5.8; range, 20–42), 0–8
children (mean = 1.4, SD = 1.7) and at least a high school education. They generated 378 cycles
of data, of which 346 (or 92.0%) had a CPEFM peak, 336 (or 89.4%) had a cervical mucus peak
and 315 had both a CPEFM and cervical mucus (CM) peak. The length (of the 346 CPEFM
cycles) was from 22 to 42 days with a mean of 29.1days (SD =3.2). The following results are from
the 346 charts/cycles that had a CPEFM peak.
3.2. Beginning and peak of the fertile phase
The beginning of the fertile window was, on average, day 11.8 (SD = 3.4) as determined
by the CPEFM monitor and on day 9.9 (SD = 3.0) by cervical mucus (t =-9.16, p <0.001). The
correlation between the two parameters (n = 331) was r = 0.43, p <0.001. The average first day of
peak fertility determined by the monitor was 16.5 (SD = 3.6; range, 8 –27) and by cervical mucus
16.3 (SD = 3.7; range, 6–39) (t =-1.91, p <0.06). The correlation between the mucus “peak” and
CPEFM “peak” (n = 315) was r = 0.85, p <0.001.
3.3. Length of the fertile phase
The mean length of the fertile phase as determined by the first day of cervical mucus
through 3 full days past the peak day of cervical mucus was 10.9 days (SD = 3.7). The mean
length of the fertile phase as determined by the CPEFM was 6.7 days (SD = 3.1). There was a
statistical difference between the mean length of fertility as determined by the two methods (t =
18.80, p <0.001; r = 0.27, p <0.001). Fig. 1 shows a visual comparison of the beginning, peak and
length of the fertile phase as determined by the CPEFM and cervical mucus assessment.
3.4. Other statistical parameters
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The average number of “high” day readings before the 2 “peak” days on the monitor was
4.0 (SD = 2.72) and the average total days of “peak type” mucus before the mucus “peak” was 3.7
(SD = 2.7) (r = 0.201, p <0.01). Two-hundred and eight (61.0%) of the 341 CPEFM cycles (with
“high” and “peak days”) had 5 days or more of “high” or “peak” fertility readings on the CPEFM
before the estimated day of ovulation. There was a range of 1–16 days of “high” days before the
first CPEFM “peak.” There were 246 (or 73.5%) of the cycles that had 5 days or more of mucus
days before the estimated day of ovulation. The beginning of mucus ranged from 18 days before
to 5 days after the estimated day of ovulation.
3.5. Mucus ratings
The average mucus ratings ranged from a low of 3.4 (SD =1.92) 6 days before the
estimated day of ovulation to 6.6 (SD =1.76) the day before the estimated day of ovulation. The
highest mucus ratings occurred on the 2 days before the estimated day of ovulation; see Fig. 2 for
a graph of the mucus ratings. The mucus ratings dip to an average of 4.2 (SD = 2.2) the day after
the estimated day of ovulation. Assuming that the higher ratings of mucus (i.e., the 7–8 ratings)
coincide with higher levels of urinary E3G as indicated by a “high” reading on the monitor, Fig. 3
shows the frequency of the “7–8” mucus ratings in comparison with the frequency of “high”
readings on the monitor the 6 days before the first “peak” monitor reading. The differences in
frequency between the 7–8 mucus ratings and the “high” readings range from a low of “5” six days
before the monitor “peak” to “52” two days before the monitor “peak.”

4. Discussion
The beginning of the fertile phase as determined by the CPEFM is, on average, almost 2
days later than the beginning of fertile phase as determined by the self-observation of cervical
mucus. These results make sense in that the monitor is based on an elevated threshold level of
urinary estrogen and is designed to target the high and peak days of fertility, i.e., narrow the fertile
window. The first externally observed signs of cervical mucus probably reflect a lower level of
circulating estrogen. A previous study demonstrated a fairly strong correlation between the first
day of observed mucus and the first significant rise of urinary estrogen [12]. The average number
of “high” day readings before the peak day of the monitor and the number of “peak type mucus”
days before the peak day of cervical mucus were similar (4.0 vs. 3.7). This also makes
physiological sense because higher estrogen levels probably stimulate the higher quality of
cervical mucus. However, the correlation between the two parameters was fairly low (r = 0.16, p <
0.1).
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The average day for the peak of fertility by the CPEFM and the self-observation of cervical
mucus were very similar (i.e., day 16). The correlation of 0.85 (although high) is somewhat lower
than found in previous studies (i.e., around 0.98) that correlated serum or urinary LH with the
cervical mucus peak [4]. A recent study of 15 women in Turkey who generated 30 cycles of data
with cervical mucus observations and urinary LH also showed that the average day of the LH
surge and the peak mucus day was similar (i.e., day 13) [13]. The average length of the fertile
phase by self-observation of cervical mucus in the Turkey study was 10 days.
The graph in Fig. 2 of the mean pattern of self-rated mucus before and after the estimated
day of ovulation found in the current study was similar to the mucus patterns in two previous
studies and also similar to the fecundity curve found in probability research [2, 4, 14]. The 2 “peak”
days of self-rated cervical mucus equate with the 2 days of the highest fecundity in the menstrual
cycle. This makes sense physiologically because sperm need good quality cervical mucus to
survive, filter out poor quality sperm, to be capacitated and to seek out a viable egg (ovum). It also
makes sense physiologically that the higher-rated mucus would coincide with the higher threshold
of urinary E3G that the monitor detects. This is demonstrated by the close frequency of the “7–8”
rated mucus with the frequency of the “high” readings on the monitor the 6 days before the urinary
LH surge as seen in Fig. 3.
The fact that the average length of the fertile phase as determined by cervical mucus was
statistically longer by almost 4 days as compared to the CPEFM fertile phase is not surprising.
The fertility monitor was designed to narrow the fertile window and past studies that have shown
that cervical mucus observations overestimate the fertile window by almost 200%, i.e., on
average, about 4 days more than necessary. Most cervical mucus only methods include the
menses as days of potential fertility and, therefore, add another 3–5 days to the time of
abstinence. Cervical mucus monitoring also underestimated the beginning of the estimated 6-day
fertile phase in about 26% of the cycles in this study. However, as expected, the CPEFM misses
the beginning of the fertile window about 40% of the time.
The monitor tends to be more accurate in estimating the day of ovulation and the end of
fertility. In a recent study on the CPEFM, ovulation as detected by ultrasound occurred 91.1% of
the time during the 2 peak days on the monitor and 97.0% during the 2 peak days plus 1 (i.e., the
high day after the peak) in 135 of 149 ovulatory cycles [9]. Ovulation never occurred before the
first peak day. Studies on the peak of cervical mucus as a predictor of ovulation showed that the
peak day can be off as much as 3 days or more and demonstrated that urinary LH is a more
accurate predictor of ovulation [3, 4, 15]. However, in about 1 out of 10 cycles, the monitor will not
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provide or detect a LH surge and record a “peak” day. In about 1 in 20 cycles there will be no peak
in cervical mucus. A recent study detected a peak day of cervical mucus in only 75% (n = 215) of
the 283 ultrasound confirmed ovulatory cycles [15]. The “peak” mucus absent cycles might reflect
an anovulatory cycle. Proponents of mucus only methods suggest that if there is no mucus, then
the woman is not fertile. However, research indicates that there is a probability of pregnancy even
on dry mucus days in the actual 6-day fertile phase [16].
The implication these results have for women trying to achieve a pregnancy is that the use
of the “high” and “peak” days on the fertility monitor and the peak days of cervical mucus are the
best days to have intercourse to achieve pregnancy [17]. Focused intercourse on the high-quality
days of cervical mucus have shown that they result in achieving pregnancy at a greater rate than
random acts of intercourse throughout the menstrual cycle [18]. There might be some benefit to
combining the two methods of estimating the fertile phase for women trying to achieve a
pregnancy. One reason is that the peak in cervical mucus can be off by as much as 3 days and
sometimes more. The monitor might help to pinpoint the high fertile days more accurately.
Cervical mucus is also more subjective and when there is continuous mucus due to infections or
irritations, the mucus sign can be confusing. However, without good cervical mucus present, the
likelihood of pregnancy is diminished.
Use of the CPEFM and cervical mucus monitoring together as a means to avoid
pregnancy might be beneficial. Having two markers to estimate the beginning, peak and end of
the fertile time could be thought of as a double check. A recent European study that compared a
double-check method (cervical mucus and a calendar count) with a single-check method found
that the double-check method was somewhat more effective in helping couples to avoid
pregnancy [19]. However, a downside is that this results in the risk of uncorrelated signs of fertility,
e.g., the peak in mucus and the peak in LH are off. Users of this method would also have to realize
that in approximately 8 –10% of their cycles, there would be no “peak” indication provided by the
monitor. Furthermore, the monitor was designed only for women who have cycles between 21
and 42 days. Teaching couples and women how to monitor the two signs of fertility and to interpret
them makes the process much more complex. The complexity of using both markers might also
decrease the compliance with instructions and continuation of use. Users of the CPEFM and a
similar fertility monitor (the Persona) have found the ease of use as a single measure of fertility to
be high [20].
Use of the monitor as a sole source of avoiding pregnancy would be easier and more
accurate if the monitor provided a longer preovulatory warning of fertility, i.e., detected a lower
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threshold of estrogen. On average, the monitor provides a long-enough warning time in about
60% of the cycles. Therefore, to use the monitor as a method to avoid pregnancy would require
the use of another marker, unless the woman user is comfortable with a 60% accuracy for the
beginning of the fertile phase or uses the monitor as a postovulatory device only. One of the
easiest markers would be to use a simple formula as a double-check for the beginning of the
fertile time. For example, the earliest first peak day of the last 6 –12 cycles indicated by the
monitor minus 5 days. The end of fertility would be the last day of “peak” on the monitor plus a
count of 2 or 3 days, depending on how conservative you would want to be. Studies are underway
to determine the effectiveness of these two approaches in using the CPEFM monitor as an aid to
estimating the fertile window.
Problems that can occur when two biological signs are used to determine the fertile phase
is that one of the two fertile signs is not observed or present or that the fertile signs do not
correlate. When using the monitor, the “peak” of the monitor (i.e., the LH surge) should override
the “peak” in cervical mucus. This is recommended because the monitor is actually measuring the
hormone rather than a reaction to it. Furthermore, as previously stated, recent research has
indicated that the LH surge is more accurate than the peak in cervical mucus [3, 15]. When the
peak on the monitor is not present, it is the most problematic. This can be solved by utilizing
another LH test in the evening to increase the likelihood of picking up the LH surge. Or you could
use temperature recordings to verify the postovulatory phase or a calendar formula for the end of
the fertile phase. A calendar formula is built into the electronic algorithm of the Persona monitor to
determine the end of the fertile phase when the LH surge is not detected. Because the Persona
utilizes the same technology as the CPEFM, most likely, about 1 in 10 of the cycles monitored will
not have a detected LH surge [21].
The implications for health professionals are that both the CPEFM and the tracking of
cervical mucus could be recommended for those women/couples trying to achieve pregnancy [17].
However, the use of cervical mucus will necessitate training and guidance. The use of the monitor
for avoiding pregnancy with other markers of fertility has promise. However, the monitor is not
recommended for use in avoiding pregnancy at this time. Protocols for such use are currently in
review and research.
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Appendix
Figure 1
Comparison of the mean beginning, peak and length of the fertile phase between the
Clearplan Easy Fertility Monitor and self-assessed cervical mucus.

Figure 2
Average self-observed cervical mucus ratings based on 1–8 scale (1 = no mucus to 8 =
peak).
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Figure 3
Bar graph comparing the frequency of “high” readings on the Clearplan monitor 6 days
before the first Clearplan “peak” with the frequency of 7–8 mucus ratings 6 days before
the Clearplan “peak.”
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